Rare diseases
Investigational molecules
Locations
Back to Czechia342 clinical trials in Olomouc, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
CzechiaStudy on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma
CzechiaLong-term Study on the Safety and Efficacy of Efgartigimod in Adults with Primary Immune Thrombocytopenia
CzechiaStudy on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
CzechiaStudy Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma
CzechiaStudy of AZD5305 Alone and with Other Cancer Drugs for Patients with Advanced Solid Tumors
CzechiaStudy on TTX-030, Budigalimab, and Chemotherapy for Untreated Metastatic Pancreatic Cancer Patients
CzechiaStudy of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation
CzechiaStudy Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
CzechiaStudy of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)
CzechiaStudy of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer
CzechiaStudy of PF-07220060 and PF-07104091 with Endocrine Therapy for Patients with Advanced HR-positive HER2-negative Breast Cancer
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on multiple cancer types, including metastatic prostate cancer, lung cancer, and colorectal cancer. Research emphasizes innovative treatment approaches and combination therapies.
These trials aim to improve survival rates and treatment effectiveness across various cancer types.
Studies investigating treatments for heart failure prevention, obesity management, and cardiovascular disease. Focus on innovative therapeutic approaches and combination treatments.
Research aims to reduce cardiovascular events and improve patient outcomes.
Clinical investigations targeting Crohn's disease, chronic rhinosinusitis, and other inflammatory conditions. Studies evaluate novel therapeutic approaches and treatment optimization.
Research focuses on improving treatment responses and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
